Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Biocon Limited ( (IN:BIOCON) ).
Biocon Limited has announced that CRISIL Ratings Limited has reaffirmed its credit ratings for the company’s bank facilities, maintaining a long-term rating of Crisil AA+/Stable and a short-term rating of Crisil A1+. This reaffirmation reflects Biocon’s strong financial position and stability, which is crucial for its continued operations and growth in the competitive biopharmaceutical industry.
More about Biocon Limited
Biocon Limited is a prominent player in the biopharmaceutical industry, primarily engaged in the development and manufacturing of biologics, biosimilars, and generic formulations. The company focuses on providing affordable healthcare solutions and has a significant presence in both domestic and international markets.
Average Trading Volume: 157,109
Technical Sentiment Signal: Strong Buy
Current Market Cap: 516B INR
For an in-depth examination of BIOCON stock, go to TipRanks’ Overview page.